-transparent.png){kind=logo}
Results are presented for a series of 29 patients, 14 males and 15 females, with serious respiratory infections, in which fosfomycin proved effective. In all cases the study was completed by bacteriological, clinical, radiological and analytical controls. The average dose was 6 g/day (3 g orally and 3 g intramuscularly) for 1 or 2 weeks. The four isolated were P. aeruginosa, E. coli, Klebsiella-Enterobacter and D. pneumoniae. Overall sensitivity percentages were best for fosfomycin, gentamicin and colistin. Of the 29 germs isolated, only one strain of P. aeruginosa became resistant: this represents 3% resistance development. No side effects of intolerance or signs of hepatorenal insufficiency were observed during the treatment. Of the 29 patients treated, 22 were clinically cured, denoting 76% success.
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1977,
Chemotherapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1977,
Chemotherapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1977,
Chemotherapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
December 1978,
Minerva medica,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
December 1987,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1977,
Chemotherapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1978,
Giornale italiano di chemioterapia,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
October 2017,
Expert review of anti-infective therapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
September 1984,
The Journal of antimicrobial chemotherapy,
R Bacardí, and
J Tornos, and
I Moga, and
N Martí, and
P Alomar, and
L Gaztelurrutia, and
C Villalonga
January 1977,
Chemotherapy,
